22NW, LP
In its 13F for Q3 2024 (holdings as of September 30, 2024, filed November 14, 2024), 22NW, LP reported 13 stock positions worth $119.3 million. Its top holding was Foster (lb) Class A (FSTR) at 22.5% of the portfolio, followed by Lifecore Biomedical (LFCR, 19.8%) and Sterling Infrastructure (STRL, 12.1%). Compared with Q2 2024, it added to 3. The biggest buy was Culp (CULP, shares +29%).
- Most Recent 13F
- Q2 2026
- Location
- SEATTLE, WA
- CIK
- 0001694297
- Portfolio Value
- $119.3M (Q3 2024)
- SEC Filing
- 0001214659-24-019159 ↗ filed Nov 14, 2024
Holdings Value
Holdings 13 stocks · $119.3M
| FSTR Foster (lb) Co. Class A | 22.49% | 1,313,121 | $26.8M | No change |
| LFCR Lifecore Biomedical Inc. | 19.83% | 1,755,161 | $23.7M | No change |
| STRL Sterling Infrastructure Inc. | 12.13% | 99,783 | $14.5M | No change |
| CULP Culp Inc. | 8.76% | 1,594,390 | $10.4M | Add +28.9% |
| ANEB Anebulo Pharmaceuticals Inc. | 8.68% | 5,366,290 | $10.4M | No change |
| BBSI Barrett Business SVCS Inc. | 8.33% | 264,904 | $9.9M | No change |
| PFX Phenixfin Corp. | 4.69% | 117,885 | $5.6M | No change |
| DHX Dhi Group Inc. | 4.02% | 2,603,643 | $4.8M | Add +25.9% |
| FARM Farmer Bros Co. | 3.25% | 1,955,526 | $3.9M | No change |
| LNTH Lantheus Holdings Inc. | 3.18% | 34,562 | $3.8M | No change |
| MTW Manitowoc Company Inc. | 2.87% | 356,115 | $3.4M | No change |
| SSKN Strata Skin Sciences Inc. | 1.24% | 536,995 | $1.5M | No change |
| PMDI Psychemedics Corp. | 0.53% | 276,034 | $638K | Add +0.6% |
Portfolio Sells Q2 2024 → Q3 2024
| None this quarter. | |||
Portfolio Buys Q2 2024 → Q3 2024
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 14 | $104.7M | NSP, NKTR, SRI, FOXF, CMT |
| Q1 2026 | 16 | $145.9M | FSTR, NKTR, LFCR, NSP, MLYS |
| Q4 2025 | 20 | $237.6M | ANEB, FSTR, LFCR, NKTR, RGNX |
| Q3 2025 | 21 | $212.3M | ANEB, FSTR, LFCR, NKTR, SRI |
| Q2 2025 | 21 | $158.8M | FSTR, LFCR, ANEB, SRI, DHX |
| Q1 2025 | 20 | $149.1M | LFCR, FSTR, ANEB, STRL, CULP |
| Q4 2024 | 16 | $158.5M | FSTR, LFCR, ANEB, STRL, BBSI |
| Q3 2024 | 13 | $119.3M | FSTR, LFCR, STRL, CULP, ANEB |
| Q2 2024 | 13 | $117.2M | FSTR, LFCR, ANEB, STRL, BBSI |
| Q1 2024 | 13 | $116.1M | FSTR, ANEB, STRL, LFCR, BBSI |